查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855814

2025年全球心血管基因體學檢測組合市場報告

Cardiogenomics Testing Panels Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，心臟基因組學檢測市場發展迅速，預計到2024年將達到13.8億美元，到2025年將達到15.5億美元，複合年成長率為12.7%。預測期內的成長歸因於基因檢測報銷政策的擴大、基因諮詢服務的增加、對早期診斷和預防的重視、公眾意識提升的提高以及遠端醫療和遠距離診斷的廣泛應用。

預計未來幾年，心血管基因組學檢測市場將快速成長，到2029年市場規模將達到24.8億美元，複合年成長率（CAGR）為12.4%。預測期內的成長主要歸因於心血管疾病盛行率的上升、人們對遺傳易感性的認知不斷提高、個人化醫療需求的成長、次世代定序儀的普及以及醫療保健領域對基因組學投資的增加。預測期內的關鍵趨勢包括次世代定序儀的發展、人工智慧在數據分析中的應用、多基因檢測組合的開發、微陣列技術的進步以及基因組數據在電子健康記錄中的整合。

心血管基因組學檢測是一種基因檢測，它檢查多個基因，以確定您患心血管疾病（如心肌病、心律不整和遺傳性高膽固醇症）的遺傳風險，從而支持早期診斷、個人化治療和家族風險評估。

心血管基因組學檢測主要分為單基因檢測、多基因檢測和全EXOME顯子定序。單基因檢測針對特定基因，檢測與特定遺傳疾病相關的突變或變異。所採用的技術包括次世代定序、基於PCR的檢測和微陣列技術。這些檢測被醫院、診所、診斷實驗室、學術和研究機構以及其他終端使用者用於遺傳性心血管疾病、心律不整、心肌病和先天性心臟疾病等領域。

美國關稅的快速上漲以及持續到2025年春季的貿易摩擦，對醫療設備行業產生了重大影響，尤其是進口診斷成像設備部件、手術用不銹鋼和塑膠耗材。醫院和診所抵制價格上漲，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要重新認證設備，從而延緩產品上市時間。企業正透過關鍵零件的雙重採購、擴大國內同質化產品的生產以及加速研發經濟高效材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）最新系列報告的一部分，提供心血管基因組學檢測組合市場統計數據，包括全球市場規模、區域佔有率、競爭對手及其市場佔有率、詳細的市場細分、市場趨勢和機遇，以及您在心血管基因組學檢測組合行業取得成功所需的數據。本心血管基因組學檢測組合市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切觀點。

遺傳性心血管疾病盛行率的上升預計將推動心臟基因組檢測市場的成長。遺傳性心血管疾病（ICD）包括由父母遺傳給子女的心臟和血管疾病。基因檢測和診斷技術的進步使得以往難以發現的疾病能夠被更準確地檢測到，從而導致確診病例的增加。心臟基因組檢測心臟疾病的診療提供支持，有助於早期診斷、風險評估和個人化治療方案的發展。例如，英國社區健康中心聯合戰略需求評估中心（Joint Strategic Needs Assessment）在2025年2月發布的報告顯示，布萊克浦2023年記錄的心血管疾病死亡人數為185人，而2022年為178人。這種盛行率的上升正在推動心臟基因組檢測市場的擴張。

預計醫療保健支出的成長將推動心血管基因組學檢測市場的發展。醫療保健支出包括政府、私人機構和個人用於提供、維護和改善醫療保健服務的總資源。支出成長的促進因素是慢性疾病負擔日益加重，這些疾病需要長期管理、持續監測和專業介入。這些支出透過資助先進的基因分析來支持心血管基因組學檢測，從而實現遺傳性心血管疾病的早期發現和預防，改善患者預後並降低長期成本。例如，美國聯邦政府機構醫療保險和醫療補助服務中心（CMS）於2023年12月報告稱，2022年美國醫療保健支出將增加4.1%，達到4.5兆美元，高於2021年的3.2%。這一趨勢正在推動心血管基因組學檢測市場的成長。

2022年3月，美國醫療保健解決方案供應商LetsGetChecked收購了Veritas Genetics Inc.和Veritas Intercontinental SL，具體金額未揭露。此次收購旨在利用全基因組定序技術，將詳細的基因數據整合到可擴展的診斷和虛擬護理平台中，從而提供全面、個人化的醫療保健生命週期服務，並由臨床專家提供切實可行的建議和生活方式指導。 Veritas Genetics Inc.和Intercontinental SL是兩家提供心臟基因組學檢測的美國生物技術公司。

心血管基因組學檢測市場由提供基因風險評估、早期診斷和個人化治療方案等服務的營業單位所獲得的收入組成。市場價值還包括服務供應商銷售的或包含在其服務中的相關產品的價值。心血管基因組學檢測市場還包括綜合性心肌病檢測組合、心律不整檢測組合以及直接面對消費者的基因組分析的銷售額。此市場價值為“出廠價”，即產品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心血管基因組學檢測小組：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球心血管基因組學檢測市場：成長率分析
  • 全球心血管基因體學檢測組合市場表現：規模與成長，2019-2024年
  • 全球心血管基因組學檢測組合市場預測：規模與成長，2024-2029年，2034年預測
  • 全球心血管基因組學檢測組合：潛在市場規模 (TAM)

第6章 市場細分

  • 全球心血管基因體學檢測組合市場依產品類型、效能及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 單基因檢測
  • 多基因檢測
  • 全EXOME定序panel
  • 全球心血管基因體學檢測組合市場（依技術分類）：績效及預測，2019-2024年、2024-2029年預測、2034年預測
  • 次世代定序儀
  • 基於PCR的檢測
  • 微陣列
  • 其他技術
  • 全球心血管基因體學檢測組合市場：按應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 遺傳性心血管疾病
  • 心律不整
  • 心肌病
  • 先天性心臟疾病
  • 其他應用
  • 全球心血管基因體學檢測組合市場：依最終用戶分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 醫院和診所
  • 診斷實驗室
  • 學術研究機構
  • 其他最終用戶
  • 全球心血管基因組學檢測組合市場：按單基因組合、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 離子通道基因檢測
  • 結構性心臟病基因檢測
  • 心律不整基因檢測
  • 全球心血管基因組學檢測組合市場：按多基因組合、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 心肌病專家組
  • 心律不整小組
  • 先天性心臟疾病醫師組
  • 全球心血管基因組學檢測組合市場：細分：全EXOME序組合，按類型、表現和預測（2019-2024 年、2024-2029 年預測、2034 年預測）
  • 標靶心血管EXOME組檢測
  • 全面EXOME組檢測
  • 研究EXOME面板

第7章 區域和國家分析

  • 全球心血管基因體學檢測組合市場：按地區、績效及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 全球心血管基因體學檢測組合市場：按國家/地區、績效和預測分類，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 心血管基因組學檢測組合市場：競爭格局
  • 心血管基因組學檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Illumina Inc.
  • Actia Group
  • Invitae Corporation
  • Fulgent Genetics Inc.
  • GeneDx Inc.
  • Ambry Genetics Corporation
  • Helix OpCo Inc.
  • Centogene Gmbh
  • Blueprint Genetics Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Genes2Me Pvt. Ltd.
  • BioAro Inc.
  • GENinCode Plc
  • Igenomix SL
  • Asper Biotech Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年心血管基因體學檢測市場：提供新機會的國家
  • 2029年心血管基因體學檢測組合市場：新興細分市場機會
  • 2029年心血管基因組學檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38463

Cardiogenomics testing panels are genetic tests that examine multiple genes to determine inherited risks for cardiovascular diseases, including cardiomyopathies, arrhythmias, and familial hypercholesterolemia. They support early diagnosis, personalized treatment, and assessment of family risk.

The primary product types of cardiogenomics testing panels are single-gene panels, multi-gene panels, and whole exome sequencing panels. Single-gene panels test a specific gene to detect mutations or variants linked to a particular inherited condition or disease. The technologies employed include next-generation sequencing, PCR-based testing, microarrays, and others. These panels are applied in areas such as inherited cardiovascular diseases, arrhythmias, cardiomyopathies, congenital heart diseases, and others, and are used by hospitals and clinics, diagnostic laboratories, academic and research institutions, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The cardiogenomics testing panels market research report is one of a series of new reports from The Business Research Company that provides cardiogenomics testing panels market statistics, including cardiogenomics testing panels industry global market size, regional shares, competitors with a cardiogenomics testing panels market share, detailed cardiogenomics testing panels market segments, market trends and opportunities, and any further data you may need to thrive in the cardiogenomics testing panels industry. This cardiogenomics testing panels market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cardiogenomics testing panels market size has grown rapidly in recent years. It will grow from $1.38 billion in 2024 to $1.55 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to expanding reimbursement policies for genetic tests, an increasing number of genetic counseling services, greater focus on early diagnosis and prevention, rising public awareness initiatives, and wider adoption of telemedicine and remote diagnostics.

The cardiogenomics testing panels market size is expected to see rapid growth in the next few years. It will grow to $2.48 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, growing awareness of genetic predispositions, higher demand for personalized medicine, greater availability of next-generation sequencing, and rising healthcare investments in genomics. Key trends in the forecast period include advancements in next-generation sequencing, integration of artificial intelligence for data analysis, development of multi-gene panels, progress in microarray technology, and incorporation of genomic data with electronic health records.

The rising prevalence of inherited cardiovascular diseases is expected to drive growth in the cardiogenomics testing panels market. Inherited cardiovascular diseases (ICDs) include heart and blood vessel disorders passed down genetically from parents to offspring. Advances in genetic testing and diagnostics have contributed to an increase in diagnosed cases by enabling more precise detection of previously unidentified conditions. Cardiogenomics testing panels assist in inherited cardiovascular diseases by analyzing genetic mutations responsible for hereditary heart disorders, facilitating early diagnosis, risk evaluation, and personalized treatment plans. For example, in February 2025, the Joint Strategic Needs Assessment, a UK community health center, reported that Blackpool recorded 185 cardiovascular disease deaths in 2023 compared to 178 in 2022. This growing prevalence is fueling expansion in the cardiogenomics testing panels market.

Increasing healthcare expenditure is anticipated to boost the cardiogenomics testing panels market. Healthcare expenditure encompasses the total resources spent by governments, private entities, and individuals on delivering, maintaining, and improving health services and medical care. The rise in spending is driven by the growing burden of chronic diseases that require long-term management, ongoing monitoring, and specialized interventions. These expenditures support cardiogenomics testing panels by funding advanced genetic analyses that enable early detection and prevention of inherited cardiovascular conditions, improving patient outcomes and lowering long-term costs. For instance, in December 2023, the Centers for Medicare & Medicaid Services, a US federal agency, reported that healthcare spending in the US increased by 4.1% in 2022, reaching $4.5 trillion, up from 3.2% growth in 2021. This trend contributes to market growth in cardiogenomics testing panels.

In March 2022, LetsGetChecked, a US healthcare solutions provider, acquired Veritas Genetics Inc. and Veritas Intercontinental S.L. for an undisclosed amount. This acquisition aims to utilize whole genome sequencing to offer a comprehensive personalized healthcare lifecycle by integrating detailed genetic data into scalable diagnostic and virtual care platforms, delivering actionable recommendations and lifestyle guidance from clinical experts. Veritas Genetics Inc. and Intercontinental S.L. are US-based biotechnology firms providing cardiogenomics testing panels.

Major players in the cardiogenomics testing panels market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Actia Group, Invitae Corporation, Fulgent Genetics Inc., GeneDx Inc., Ambry Genetics Corporation, Helix OpCo Inc., Centogene Gmbh, Blueprint Genetics Inc., Strand Life Sciences Pvt. Ltd., Genes2Me Pvt. Ltd., BioAro Inc., GENinCode Plc, Igenomix S.L., Asper Biotech Ltd.

North America was the largest region in the cardiogenomics testing panels market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cardiogenomics testing panels report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cardiogenomics testing panels market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cardiogenomics testing panels market consists of revenues earned by entities by providing services such as genetic risk assessment, early diagnosis, and personalized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The cardiogenomics testing panels market also includes sales of comprehensive cardiomyopathy panels, cardiac arrhythmia panels, and direct-to-consumer genomic profiles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiogenomics Testing Panels Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiogenomics testing panels market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cardiogenomics testing panels ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiogenomics testing panels market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single-Gene Panels; Multi-Gene Panels; Whole Exome Sequencing Panels
  • 2) By Technology: Next-Generation Sequencing; PCR-Based Testing; Microarray; Other Technologies
  • 3) By Application: Inherited Cardiovascular Diseases; Arrhythmias; Cardiomyopathies; Congenital Heart Diseases; Other Appications
  • 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutes; Other End Users
  • Subsegments:
  • 1) By Single-Gene Panels: Ion Channel Gene Panels; Structural Heart Disease Gene Panels; Arrhythmia Gene Panels
  • 2) By Multi-Gene Panels: Cardiomyopathy Panels; Arrhythmia Panels; Congenital Heart Disease Panels
  • 3) By Whole Exome Sequencing Panels: Targeted Cardiovascular Exome Panels; Comprehensive Exome Panels; Research-Oriented Exome Panels
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Eurofins Scientific SE; Illumina Inc.; Actia Group; Invitae Corporation; Fulgent Genetics Inc.; GeneDx Inc.; Ambry Genetics Corporation; Helix OpCo Inc.; Centogene Gmbh; Blueprint Genetics Inc.; Strand Life Sciences Pvt. Ltd.; Genes2Me Pvt. Ltd.; BioAro Inc.; GENinCode Plc; Igenomix S.L.; Asper Biotech Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cardiogenomics Testing Panels Market Characteristics

3. Cardiogenomics Testing Panels Market Trends And Strategies

4. Cardiogenomics Testing Panels Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cardiogenomics Testing Panels Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cardiogenomics Testing Panels PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cardiogenomics Testing Panels Market Growth Rate Analysis
  • 5.4. Global Cardiogenomics Testing Panels Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cardiogenomics Testing Panels Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cardiogenomics Testing Panels Total Addressable Market (TAM)

6. Cardiogenomics Testing Panels Market Segmentation

  • 6.1. Global Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Gene Panels
  • Multi-Gene Panels
  • Whole Exome Sequencing Panels
  • 6.2. Global Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • PCR-Based Testing
  • Microarray
  • Other Technologies
  • 6.3. Global Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inherited Cardiovascular Diseases
  • Arrhythmias
  • Cardiomyopathies
  • Congenital Heart Diseases
  • Other Appications
  • 6.4. Global Cardiogenomics Testing Panels Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Academic And Research Institutes
  • Other End Users
  • 6.5. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Single-Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ion Channel Gene Panels
  • Structural Heart Disease Gene Panels
  • Arrhythmia Gene Panels
  • 6.6. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Multi-Gene Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiomyopathy Panels
  • Arrhythmia Panels
  • Congenital Heart Disease Panels
  • 6.7. Global Cardiogenomics Testing Panels Market, Sub-Segmentation Of Whole Exome Sequencing Panels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Targeted Cardiovascular Exome Panels
  • Comprehensive Exome Panels
  • Research-Oriented Exome Panels

7. Cardiogenomics Testing Panels Market Regional And Country Analysis

  • 7.1. Global Cardiogenomics Testing Panels Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cardiogenomics Testing Panels Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cardiogenomics Testing Panels Market

  • 8.1. Asia-Pacific Cardiogenomics Testing Panels Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cardiogenomics Testing Panels Market

  • 9.1. China Cardiogenomics Testing Panels Market Overview
  • 9.2. China Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cardiogenomics Testing Panels Market

  • 10.1. India Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cardiogenomics Testing Panels Market

  • 11.1. Japan Cardiogenomics Testing Panels Market Overview
  • 11.2. Japan Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cardiogenomics Testing Panels Market

  • 12.1. Australia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cardiogenomics Testing Panels Market

  • 13.1. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cardiogenomics Testing Panels Market

  • 14.1. South Korea Cardiogenomics Testing Panels Market Overview
  • 14.2. South Korea Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cardiogenomics Testing Panels Market

  • 15.1. Western Europe Cardiogenomics Testing Panels Market Overview
  • 15.2. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cardiogenomics Testing Panels Market

  • 16.1. UK Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cardiogenomics Testing Panels Market

  • 17.1. Germany Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cardiogenomics Testing Panels Market

  • 18.1. France Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cardiogenomics Testing Panels Market

  • 19.1. Italy Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cardiogenomics Testing Panels Market

  • 20.1. Spain Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cardiogenomics Testing Panels Market

  • 21.1. Eastern Europe Cardiogenomics Testing Panels Market Overview
  • 21.2. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cardiogenomics Testing Panels Market

  • 22.1. Russia Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cardiogenomics Testing Panels Market

  • 23.1. North America Cardiogenomics Testing Panels Market Overview
  • 23.2. North America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cardiogenomics Testing Panels Market

  • 24.1. USA Cardiogenomics Testing Panels Market Overview
  • 24.2. USA Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cardiogenomics Testing Panels Market

  • 25.1. Canada Cardiogenomics Testing Panels Market Overview
  • 25.2. Canada Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cardiogenomics Testing Panels Market

  • 26.1. South America Cardiogenomics Testing Panels Market Overview
  • 26.2. South America Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cardiogenomics Testing Panels Market

  • 27.1. Brazil Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cardiogenomics Testing Panels Market

  • 28.1. Middle East Cardiogenomics Testing Panels Market Overview
  • 28.2. Middle East Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cardiogenomics Testing Panels Market

  • 29.1. Africa Cardiogenomics Testing Panels Market Overview
  • 29.2. Africa Cardiogenomics Testing Panels Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cardiogenomics Testing Panels Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cardiogenomics Testing Panels Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cardiogenomics Testing Panels Market Competitive Landscape And Company Profiles

  • 30.1. Cardiogenomics Testing Panels Market Competitive Landscape
  • 30.2. Cardiogenomics Testing Panels Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Cardiogenomics Testing Panels Market Other Major And Innovative Companies

  • 31.1. Illumina Inc.
  • 31.2. Actia Group
  • 31.3. Invitae Corporation
  • 31.4. Fulgent Genetics Inc.
  • 31.5. GeneDx Inc.
  • 31.6. Ambry Genetics Corporation
  • 31.7. Helix OpCo Inc.
  • 31.8. Centogene Gmbh
  • 31.9. Blueprint Genetics Inc.
  • 31.10. Strand Life Sciences Pvt. Ltd.
  • 31.11. Genes2Me Pvt. Ltd.
  • 31.12. BioAro Inc.
  • 31.13. GENinCode Plc
  • 31.14. Igenomix S.L.
  • 31.15. Asper Biotech Ltd.

32. Global Cardiogenomics Testing Panels Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiogenomics Testing Panels Market

34. Recent Developments In The Cardiogenomics Testing Panels Market

35. Cardiogenomics Testing Panels Market High Potential Countries, Segments and Strategies

  • 35.1 Cardiogenomics Testing Panels Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cardiogenomics Testing Panels Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cardiogenomics Testing Panels Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer